Yusuf Yazici Selected Research

Yusuf Yazici Research Topics

Disease

40	Rheumatoid Arthritis 01/2020 - 06/2002
14	Pain (Aches) 03/2022 - 02/2007
6	Oral Ulcer (Mouth Ulcer) 01/2022 - 04/2015
6	Neoplasms (Cancer) 01/2020 - 01/2007
4	Vasculitis (Vasculitides) 10/2022 - 01/2012
4	Osteoarthritis 03/2022 - 05/2006
4	Rheumatic Diseases (Rheumatism) 09/2019 - 08/2011
3	Knee Osteoarthritis 03/2022 - 10/2020
3	Nausea 09/2021 - 04/2015
3	Ankylosing Spondylitis 12/2018 - 01/2010
3	Psoriatic Arthritis 01/2018 - 01/2010
3	Fatigue 06/2014 - 02/2007
2	Headache (Headaches) 09/2021 - 11/2019
2	Inflammation (Inflammations) 01/2021 - 11/2009
2	Diarrhea 11/2019 - 04/2015
2	Chronic Disease (Chronic Diseases) 09/2015 - 11/2009
2	Arthritis (Polyarthritis) 01/2010 - 05/2006
2	Thrombosis (Thrombus) 07/2007 - 12/2003
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2021
1	Tendinopathy (Tendonitis) 01/2021
1	Fibrosis (Cirrhosis) 01/2020
1	Eye Diseases (Eye Disease) 01/2020
1	Disease Progression 01/2020
1	Intervertebral Disc Degeneration 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Ulcer 01/2017
1	Vomiting 04/2015
1	Relapsing Polychondritis 10/2013
1	Myocarditis (Carditis) 10/2013
1	Drug-Related Side Effects and Adverse Reactions 12/2012
1	Necrosis 12/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2012
1	Autoimmune Diseases (Autoimmune Disease) 12/2012
1	Fibromyalgia (Fibrositis) 07/2012
1	Infections 02/2012
1	Aneurysm (Aneurysms) 01/2012
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2012
1	Hypertension (High Blood Pressure) 01/2012
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2009
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2007
1	Opportunistic Infections (Opportunistic Infection) 01/2007

Drug/Important Bio-Agent (IBA)

13	Methotrexate (Mexate)FDA LinkGeneric 09/2015 - 08/2002
12	Biological ProductsIBA 01/2020 - 05/2006
5	apremilastIBA 01/2022 - 04/2015
5	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 05/2009
5	Antirheumatic Agents (DMARD)IBA 01/2017 - 01/2008
4	lorecivivintIBA 03/2022 - 01/2020
4	ametantrone (HAQ)IBA 09/2019 - 04/2008
4	Infliximab (Remicade)FDA Link 01/2018 - 10/2003
4	Prednisone (Sone)FDA LinkGeneric 01/2017 - 01/2009
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 05/2009
3	Adalimumab (Humira)FDA Link 01/2020 - 10/2013
3	Phosphotransferases (Kinase)IBA 01/2020 - 01/2011
3	Certolizumab Pegol FDA Link 09/2017 - 08/2011
3	CytokinesIBA 07/2015 - 05/2006
3	tocilizumab (atlizumab)FDA Link 05/2013 - 01/2007
3	Azathioprine (Imuran)FDA LinkGeneric 12/2012 - 01/2009
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2022 - 01/2018
2	Abatacept (Orencia)FDA Link 01/2020 - 02/2012
2	Rituximab (Mabthera)FDA Link 01/2018 - 05/2011
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2017 - 10/2003
2	GlucocorticoidsIBA 07/2015 - 01/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2012 - 01/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012 - 01/2009
2	Monoclonal AntibodiesIBA 01/2010 - 01/2007
2	Anti-Citrullinated Protein AntibodiesIBA 08/2009 - 02/2007
2	antineoplaston A10 (A 10)IBA 08/2008 - 02/2007
1	salicylhydroxamic acid (SHAM)IBA 03/2022
1	ORALIT (ORS)IBA 06/2021
1	Collagenases (Collagenase)FDA Link 01/2021
1	Clk dual-specificity kinasesIBA 10/2020
1	Dyrk KinasesIBA 10/2020
1	CateninsIBA 01/2020
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2020
1	C-Reactive ProteinIBA 09/2019
1	secukinumabIBA 12/2018
1	tofacitinibIBA 08/2018
1	Janus Kinase InhibitorsIBA 08/2018
1	Biosimilar PharmaceuticalsIBA 01/2018
1	CT-P13IBA 01/2018
1	Pharmaceutical PreparationsIBA 12/2012
1	Colchicine FDA LinkGeneric 12/2012
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2012
1	Hemoglobins (Hemoglobin)IBA 01/2012
1	golimumab FDA Link 01/2010
1	CholesterolIBA 11/2009
1	AntibodiesIBA 08/2009
1	Rheumatoid FactorIBA 01/2009
1	amsonic acid (DAS)IBA 08/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2007
1	Antiphospholipid AntibodiesIBA 07/2007
1	Prednisolone (Predate)FDA LinkGeneric 02/2007
1	LipidsIBA 01/2007
1	Denosumab FDA Link 06/2006

Therapy/Procedure

12	Therapeutics 06/2021 - 06/2002
5	Biological Therapy 01/2017 - 05/2006
1	Injections 03/2022
1	Replacement Arthroplasty 06/2006